Broadmed Principal/Distributor Contact Form

Business Development And Market Analysis

We recognize the highly competitive and complex pharmaceutical environment in the MENA region and as a result we established our own specialized Scientific Business Unit (SBU).  Not only does the SBU continuously seek new opportunities and partnerships aligned with our portfolio strategy, but has the unique capability of executing a comprehensive market evaluation before commercialization. Our methodological research approaches are guided by a product’s scientific integrity, therapeutic impact, and most importantly, safety. This allows us to effectively evaluate potential market size and penetration in a highly systematic manner guided by optimizing return and focusing on fundamental therapeutic areas. The processes implemented by the SBU are dynamic allowing us to continuously evaluate new and existing products in the market and monitor competitor performance.